Skip to main content

Table 1 Eligibility criteria

From: Comparison of prasugrel and clopidogrel reloading on high platelet reactivity in clopidogrel-loaded patients undergoing percutaneous coronary intervention (PRAISE-HPR): a study protocol for a prospective randomized controlled clinical trial

Inclusion criteria Exclusion criteria
Subjects 20 to 80 years old Body weight < 50 kg
Male or female gender Contraindications for study drugs
ACS without ST-segment elevation Urgent PCI for ACS
Planned to undergo PCI Use of glycoprotein IIb/IIIa inhibitor
Patients who provided written informed consent History of transient ischemic attack
  Active internal bleeding or bleeding diathesis
  Upper gastrointestinal bleeding in the past six months
  Hemoglobin < 10 g/dl or platelets < 100,000/mm3
  Renal dysfunction (serum creatinine > 2.5 mg/dl)
  Hepatic dysfunction (serum transaminase > three times normal limit)
  1. ACS, acute coronary syndrome; PCI, percutaneous coronary intervention.